Back
Quest Diagnostics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
50
DGX
Quest Diagnostics
Last Price:
140.78
Seasonality Move:
3.29%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
41.11
Seasonality Move:
12.29%
Sell
50
Quest Diagnostics (DGX)
is a Sell
Is Quest Diagnostics a Buy, Sell or Hold?
- The current Quest Diagnostics [DGX] share price is $139.16. The Score for DGX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- DGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $40.97. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DGX Stock Price Chart
What is Quest Diagnostics's stock price today?
-
The Quest Diagnostics share price today is $139.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DGX is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $40.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight selling pressure.
DGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.19 | Buy |
Relative Strength Index (14 RSI): | 60 | Buy |
Chaikin Money Flow: | -230197 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (129.72 - 138.74) | Buy |
Bollinger Bands (100): | (126.53 - 136.51) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.41 | Sell |
Relative Strength Index (14 RSI): | 35.08 | Sell |
Chaikin Money Flow: | -198670 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.06 - 46.28) | Sell |
Bollinger Bands (100): | (43.39 - 49.39) | Sell |
DGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 137.83 | Buy |
20-day SMA: | 135.48 | Buy |
50-day SMA: | 131.91 | Buy |
200-day SMA: | 131.04 | Buy |
8-day EMA: | 138.18 | Buy |
20-day EMA: | 136.05 | Buy |
50-day EMA: | 133.25 | Buy |
200-day EMA: | 132.58 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.66 | Sell |
20-day SMA: | 42.86 | Sell |
50-day SMA: | 45.82 | Sell |
200-day SMA: | 42.07 | Sell |
8-day EMA: | 41.62 | Sell |
20-day EMA: | 42.96 | Sell |
50-day EMA: | 44.73 | Sell |
200-day EMA: | 44.3 | Sell |
Quest Diagnostics Earnings Growth & DGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.19 per share, an increase this year of $0.11 per share, and an increase next year of $0.63 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
Quest Diagnostics Technical Analysis
May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |